CLINICAL_TRIALS
trial_result
· 2017-07-06
Clinical Trial Update: Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure. [Phase 4]
Summary
Phase 4 clinical trial evaluating Renamezin in patients with chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure | Phase 4 | Status: COMPLETED